Page last updated: 2024-08-24

naphthalimides and Esophageal Neoplasms

naphthalimides has been researched along with Esophageal Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, D; Zhang, S	1
Conrad, ME; Eisenberg, P; Fisher, RI; Fleming, T; MacDonald, JS; Poplin, E	1

Trials

1 trial(s) available for naphthalimides and Esophageal Neoplasms

Article	Year
Amonafide treatment of refractory esophageal cancer. A Southwest Oncology Group study. Investigational new drugs, 1993, Volume: 11, Issue:1 Topics: Adenine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drugs, Investigational; Esophageal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Prognosis	1993

Other Studies

1 other study(ies) available for naphthalimides and Esophageal Neoplasms

Article	Year
UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway. Molecular medicine reports, 2018, Volume: 17, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Naphthalimides; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; Urea	2018

Article

Year

UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway.

Molecular medicine reports, 2018, Volume: 17, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Naphthalimides; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; Urea

2018